Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexofenadine for Albuminuria in Diabetic Kidney Disease
NCT04224428Phase 3Completed
- Sponsor
- Tanta University
- Start
- Jan 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fexofenadine in diabetic kidney disease (DKD), sponsored by Tanta University. Started Jan 2020; status: completed.
02
Drugs
fexofenadine
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT04224428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04224428.